83230-57-3

Basic information

• Product Name: Propanoic acid, 3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxy-
• CAS NO: 83230-57-3
• Molecular Formula: C13H19NO5
• Molecular Weight: 269.298
• Mol File: 83230-57-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxy-(83230-57-3)
• EPA Substance Registry System: Propanoic acid, 3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxy-(83230-57-3)

Safety Data

• Hazardous Substances Data: 83230-57-3(Hazardous Substances Data)

Upstream product

• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 1713-85-5 3-chloro-2-hydroxypropanoic acid 

Downstream Products

• 83230-60-8 phenyl 3-<(3,4-dimethoxyphenethyl)(4-methoxybenzyloxycarbonyl)amino>-2-<(tetrahydro-2-pyranyl)oxy>propionate 
• 83230-63-1 3-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-2-hydroxy-propionic acid naphthalen-1-yl ester; hydrochloride 
• 83230-56-2 phenyl 3-<(3,4-dimethoxyphenethyl)amino>-2-hydroxypropionate hydrochloride 
• 83230-61-9 3-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-2-hydroxy-propionic acid o-tolyl ester; hydrochloride 
• 83230-59-5 3-<(3,4-dimethoxyphenethyl)(4-methoxybenzyloxycarbonyl)amino>-2-<(tetrahydro-2-pyranyl)oxy>propionic acid 
• 83230-58-4 3-<(3,4-dimethoxyphenethyl)(4-methoxybenzyloxycarbonyl)amino>-2-hydroxypropionic acid 
• 83230-64-2 2-methoxybenzyl 3-<(3,4-dimethoxyphenethyl)amino>-2-hydroxypropionate 

Relevant articles and documents

propanolamines. 1. Novel β-Blockers with Ultrashort Duration of Action

Novel propanolamines were synthesized and investigated as potential ultrashort-acting β-adrenergic receptor blockers.Many of these analogues exhibited good potency and short duration.The N-ureidoalkyl analogue 85 (ACC-9089) has a potency equal to propranolol and a duration of action of about 21 min in the dog.It has been selected as a candidate for further clinical study.Structure-activity relationships and structure-duration relationships for these new β-blockers are also discussed.